1. Home
  2. RXRX vs ACHC Comparison

RXRX vs ACHC Comparison

Compare RXRX & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RXRX
  • ACHC
  • Stock Information
  • Founded
  • RXRX 2013
  • ACHC 2005
  • Country
  • RXRX United States
  • ACHC United States
  • Employees
  • RXRX N/A
  • ACHC N/A
  • Industry
  • RXRX Biotechnology: Pharmaceutical Preparations
  • ACHC Medical Specialities
  • Sector
  • RXRX Health Care
  • ACHC Health Care
  • Exchange
  • RXRX Nasdaq
  • ACHC Nasdaq
  • Market Cap
  • RXRX 1.8B
  • ACHC 2.0B
  • IPO Year
  • RXRX 2021
  • ACHC N/A
  • Fundamental
  • Price
  • RXRX $5.03
  • ACHC $21.56
  • Analyst Decision
  • RXRX Buy
  • ACHC Buy
  • Analyst Count
  • RXRX 5
  • ACHC 9
  • Target Price
  • RXRX $7.00
  • ACHC $47.94
  • AVG Volume (30 Days)
  • RXRX 29.8M
  • ACHC 1.7M
  • Earning Date
  • RXRX 08-07-2025
  • ACHC 07-30-2025
  • Dividend Yield
  • RXRX N/A
  • ACHC N/A
  • EPS Growth
  • RXRX N/A
  • ACHC N/A
  • EPS
  • RXRX N/A
  • ACHC 2.04
  • Revenue
  • RXRX $59,790,000.00
  • ACHC $3,156,417,000.00
  • Revenue This Year
  • RXRX $23.51
  • ACHC $7.83
  • Revenue Next Year
  • RXRX $53.87
  • ACHC $8.56
  • P/E Ratio
  • RXRX N/A
  • ACHC $10.53
  • Revenue Growth
  • RXRX 29.32
  • ACHC 5.48
  • 52 Week Low
  • RXRX $3.79
  • ACHC $20.36
  • 52 Week High
  • RXRX $12.36
  • ACHC $82.41
  • Technical
  • Relative Strength Index (RSI)
  • RXRX 52.35
  • ACHC 41.33
  • Support Level
  • RXRX $4.78
  • ACHC $20.47
  • Resistance Level
  • RXRX $6.07
  • ACHC $23.18
  • Average True Range (ATR)
  • RXRX 0.45
  • ACHC 0.98
  • MACD
  • RXRX 0.04
  • ACHC -0.03
  • Stochastic Oscillator
  • RXRX 44.97
  • ACHC 38.93

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

About ACHC Acadia Healthcare Company Inc.

Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.

Share on Social Networks: